Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L

Slides:



Advertisements
Similar presentations
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
Advertisements

Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Implementation of a Reliable Next-Generation Sequencing Strategy for Molecular Diagnosis of Dystrophinopathies  Melissa Alame, Delphine Lacourt, Reda.
Comprehensively Evaluating cis-Regulatory Variation in the Human Prostate Transcriptome by Using Gene-Level Allele-Specific Expression  Nicholas B. Larson,
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes  Paula Paulo, Pedro.
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors  Jeffrey M. Conroy, Sarabjot Pabla, Sean T. Glenn,
Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use  Liwen Xu, Xiaoqing You, PingPing.
Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data  David H. Spencer,
Christos Sotiriou, Chand Khanna, Amir A
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing  Jean-Marc Rey, Vincent Ducros, Pascal.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia  Joong Won Lee, Qiaofang Chen, Daniel.
Influence of RNA Labeling on Expression Profiling of MicroRNAs
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Quantitative Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays  Diana Abdueva, Michele Wing, Betty Schaub, Timothy.
Maxim B. Freidin, Neesa Bhudia, Eric Lim, Andrew G
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA  Giulia Biancon, Silvia Gimondi, Antonio Vendramin, Cristiana.
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
Christopher M. Watson, Nick Camm, Laura A
Donavan T. Cheng, Talia N. Mitchell, Ahmet Zehir, Ronak H
CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang,
A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2  Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen,
Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors  Jennifer L. Winters, Jaime I. Davila, Amber.
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Discovery and Characterization of piRNAs in the Human Fetal Ovary
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Reliable Identification of Genomic Variants from RNA-Seq Data
A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families  Wenhui L.
Eric Samorodnitsky, Jharna Datta, Benjamin M
Optimizing Cancer Genome Sequencing and Analysis
Catherine E. Cottrell, Hussam Al-Kateb, Andrew J. Bredemeyer, Eric J
ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing  Colin C. Pritchard, Christina Smith,
Identification and Validation of Genetic Variants that Influence Transcription Factor and Cell Signaling Protein Levels  Ronald J. Hause, Amy L. Stark,
Jason M. Rizzo, Rose-Anne Romano, Jonathan Bard, Satrajit Sinha 
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
The Translational Landscape of the Mammalian Cell Cycle
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Alternative Splicing QTLs in European and African Populations
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer  Kazimierz.
Utility of NIST Whole-Genome Reference Materials for the Technical Validation of a Multigene Next-Generation Sequencing Test  Bennett O.V. Shum, Ilya.
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
RNA-Stabilized Whole Blood Samples but Not Peripheral Blood Mononuclear Cells Can Be Stored for Prolonged Time Periods Prior to Transcriptome Analysis 
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
Volume 150, Issue 6, Pages (September 2012)
Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2  Lukas M. Simon, Edward S. Chen, Leonard C. Edelstein,
Molecular Monitoring of Chronic Myelogenous Leukemia
Volume 24, Issue 8, Pages (August 2018)
A Variant Detection Pipeline for Inherited Cardiomyopathy–Associated Genes Using Next-Generation Sequencing  Théo G.M. Oliveira, Miguel Mitne-Neto, Louise.
Genomic Technologies and the New Era of Genomic Medicine
A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick.
Strategy for Robust Detection of Insertions, Deletions, and Point Mutations in CEBPA, a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing.
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens  Raji.
Differential protein, mRNA, lncRNA and miRNA regulation by p53.
Universal Alternative Splicing of Noncoding Exons
KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors  Christopher L. Corless, Laura McGreevey, Ajia Town, Arin Schroeder, Troy Bainbridge,
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Volume 11, Issue 7, Pages (May 2015)
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology  Lorenza Mittempergher, Leonie J.M.J. Delahaye,
Presentation transcript:

cDNA Hybrid Capture Improves Transcriptome Analysis on Low-Input and Archived Samples  Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L. Griffith, Sean McGrath, Jin Zhang, Jason Walker, Amy Ly, Ryan Demeter, Robert S. Fulton, Winnie W. Pong, David H. Gutmann, Ramaswamy Govindan, Elaine R. Mardis, Christopher A. Maher  The Journal of Molecular Diagnostics  Volume 16, Issue 4, Pages 440-451 (July 2014) DOI: 10.1016/j.jmoldx.2014.03.004 Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 cDNA-Capture sequencing of FF lung adenocarcinomas. A: Total reads generated (light blue) and aligned (dark blue) for both RNA-Seq and cDNA-Capture across four FF lung adenocarcinomas (LUC4, LUC6, LUC13, and LUC20). B: Percentage of reads that aligned uniquely to the target regions for RNA-Seq and cDNA-Capture. C: Distribution of read alignments relative to genomic features, including coding, intergenic, intronic, ribosomal, and UTRs. D: Normalized coverage across transcripts for LUC4, LUC6, LUC13, and LUC20 from 5′ (left) to 3′ (right). E: Frequency of genes expressed at increasing coverage depth (1×, 2×, 10×, 20×, 50×, 100×, and 500×) using RNA-Seq and cDNA-Capture. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Comparison of cDNA-Capture and RNA-Seq using FF lung tumors. A: Scatterplot of LUC13 gene expression values measured by RNA-Seq and cDNA-Capture. Gene expression is measured as log2(FPKM + 1). B: Percentage of reads aligning to exon-exon junctions from RNA-Seq (gray bars) and cDNA-Capture (black bars). C: Percentage of reads spanning a splice junction that aligned to the highest 1% of expressed genes from RNA-Seq and cDNA-Capture. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Validation of expressed SNVs in LUC4 FF tissue using RNA-Seq and cDNA-Capture. Scatterplots highlight the VAF of Tier 1 SNVs discovered by whole genome sequencing relative to VAF supported by RNA-Seq (A) and cDNA-Capture (B) in LUC4 using FF tissue. Each protein-coding gene harboring an SNV is colored based on its normalized expression level [0 FPKM (yellow) to 10 + FPKM (red)]. C: Correlation of expressed SNVs detected by cDNA-Capture or RNA-Seq and their corresponding normalized expression values. SNVs are color-coded based on whether they are found by both approaches (green), neither approach (black), cDNA-Capture only (yellow), or RNA-Seq only (red). The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Comparison of cDNA-Capture and RNA-Seq using archived material. A: Total reads generated and aligned from RNA-Seq and cDNA-Capture on FFPE material in lung adenocarcinomas LUC6 and LUC7. B: Percentage of reads that aligned uniquely to the target regions for RNA-Seq and cDNA-Capture. C: Distribution of read alignments relative to genomic features, including coding, intergenic, intronic, ribosomal, and UTRs. D: Normalized coverage across transcripts. E: Dynamic range of gene coverage at varying depths. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 5 Comparison of cDNA-Capture and RNA-Seq using FF and archived material. Scatterplots comparing LUC6 (A) and LUC7 (B) gene expression values calculated from FFPE material using cDNA-Capture and RNA-Seq. The least-squares regression line is shown in gray and the 45° line in black. Gene expression is measured as log2(FPKM + 1). Correlation of LUC6 (C) and LUC7 (D) gene expression values measured from FFPE and FF material using cDNA-Capture. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 6 Validation of expressed Tier 1 SNVs using FFPE material. Scatterplots highlight concordance between expressed Tier 1 SNVs using cDNA-Capture and RNA-Seq on FFPE and FF material. The x and y axes indicate the normalized expression level (FPKM) of the genes harboring the SNVs. Only Tier 1 SNVs with at least one read supporting the variant are displayed. Circles indicate SNVs supported by both RNA-Seq and cDNA-Capture, squares for SNVs supported by only RNA-Seq, and diamonds for SNVs supported only by cDNA-Capture. For SNVs detected by both RNA-Seq and cDNA-Capture, the color indicates the mean VAF between cDNA-Capture and RNA-Seq. Otherwise, the color indicates the VAF of the approach validating the SNV. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 7 Differential gene expression analysis using cDNA-Capture on low-input libraries. A: Spearman rank correlation of edgeR P values between varying levels of RNA input. B and C: Venn diagrams show the overlap between the down- (B) and up-regulated (C) genes among the 60, 50, 10, and 2 ng input amounts. The total number of differentially expressed genes is shown under the RNA input. These plots suggest that the reliability of discovering differentially expressed genes diminishes for RNA inputs <10 ng. The Journal of Molecular Diagnostics 2014 16, 440-451DOI: (10.1016/j.jmoldx.2014.03.004) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions